GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nuwellis Inc (NAS:NUWE) » Definitions » Cyclically Adjusted Revenue per Share

Nuwellis (Nuwellis) Cyclically Adjusted Revenue per Share : $7,511.03 (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Nuwellis Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Nuwellis's adjusted revenue per share for the three months ended in Mar. 2024 was $0.295. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $7,511.03 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Nuwellis's average Cyclically Adjusted Revenue Growth Rate was -13.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -16.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -24.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Nuwellis was -16.00% per year. The lowest was -31.30% per year. And the median was -22.10% per year.

As of today (2024-05-23), Nuwellis's current stock price is $0.22. Nuwellis's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $7,511.03. Nuwellis's Cyclically Adjusted PS Ratio of today is 0.00.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Nuwellis was 365.53. The lowest was 0.01. And the median was 0.07.


Nuwellis Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Nuwellis's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuwellis Cyclically Adjusted Revenue per Share Chart

Nuwellis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18,897.10 12,984.50 10,459.80 8,920.78 7,684.01

Nuwellis Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,640.54 8,337.51 8,045.29 7,684.01 7,511.03

Competitive Comparison of Nuwellis's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Nuwellis's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nuwellis's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nuwellis's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Nuwellis's Cyclically Adjusted PS Ratio falls into.



Nuwellis Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nuwellis's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.295/131.7762*131.7762
=0.295

Current CPI (Mar. 2024) = 131.7762.

Nuwellis Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 0.000 99.070 0.000
201503 0.000 99.621 0.000
201506 0.000 100.684 0.000
201509 0.000 100.392 0.000
201512 0.000 99.792 0.000
201603 0.000 100.470 0.000
201606 0.000 101.688 0.000
201609 0.000 101.861 0.000
201612 0.000 101.863 0.000
201703 0.000 102.862 0.000
201706 0.000 103.349 0.000
201709 0.000 104.136 0.000
201712 0.000 104.011 0.000
201803 103.700 105.290 129.787
201806 10,990.000 106.317 13,621.746
201809 12,390.909 106.507 15,330.744
201812 8,817.647 105.998 10,962.066
201903 1,215.000 107.251 1,492.842
201906 1,677.000 108.070 2,044.876
201909 1,252.000 108.329 1,522.983
201912 683.500 108.420 830.741
202003 326.000 108.902 394.476
202006 143.308 108.767 173.624
202009 95.200 109.815 114.239
202012 75.704 109.897 90.776
202103 59.938 111.754 70.676
202106 38.585 114.631 44.356
202109 26.099 115.734 29.717
202112 15.638 117.630 17.519
202203 18.343 121.301 19.927
202206 21.076 125.017 22.216
202209 19.667 125.227 20.696
202212 4.364 125.222 4.592
202303 1.622 127.348 1.678
202306 1.563 128.729 1.600
202309 1.294 129.860 1.313
202312 0.449 129.419 0.457
202403 0.295 131.776 0.295

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Nuwellis  (NAS:NUWE) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Nuwellis's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.22/7511.03
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Nuwellis was 365.53. The lowest was 0.01. And the median was 0.07.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Nuwellis Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Nuwellis's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuwellis (Nuwellis) Business Description

Industry
Traded in Other Exchanges
Address
12988 Valley View Road, Eden Prairie, MN, USA, 55344
Nuwellis Inc is a medical device company. Its solutions include Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.
Executives
David Mcdonald director 6 KEMPTON PLACE, #12, SARATOGA SPRINGS NY 12866
Archelle Georgiou Feldshon director 1420 SHORELINE DRIVE, WAYZATA MN 55391
Robert Benjamin Scott officer: Chief Financial Officer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Michael Kendrick Mccormick director 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Gregory D Waller director 1717 W COLLINS AVENUE, ORANGE CA 92867
Jon W Salveson director 800 NICOLLET MALL, MINNEAPOLIS MN 55402
Nestor Jr. Jaramillo officer: Chief Commercial Officer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Lynn Larson Blake officer: Chief Financial Officer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
George Montague officer: CFO and Treasurer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Neil P Ayotte officer: SVP, Secretary, GC & CCO 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Paul Wotta officer: Principal Accounting Officer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Claudia Drayton officer: Chief Financial Officer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Thomas P. Lynch officer: Chief Legal/Compliance Officer 3344 N. TORREY PINES COURT, LA JOLLA CA 92037
Steven Frank Brandt director 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Maria Rosa Costanzo director 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344